Silvana Lay

Silvana Lay serves as the Director of Access and Public Affairs at Fifarma, where she has been instrumental in addressing issues related to the accessibility of innovative medications in Costa Rica. Her insights reveal that only 19% of globally approved innovative molecules are marketed in the country, emphasizing the significant delays patients face in obtaining new treatments.